Cymabay Therapeutics
AcquiredGilead Sciences
Newark, United States · Founded 2000 · $320.7M raised
- Headquarters
- Newark, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Website
- cymabay.com
- Total Funding
- $320.7M
- Last Round
- $85.0M Venture RoundJan 2023
- Rounds
- 4
- Acquired by
- GileadFeb 2024
About
Clinical-stage biopharmaceutical company developing therapies for liver and other chronic diseases, acquired by Gilead Sciences in 2024.
Summary
Cymabay Therapeutics is a Biotech company based in Newark, United States, founded in 2000. It has raised $320.7M in total across 4 rounds, most recently a $85.0M Venture Round round in Jan 2023. Investors include Gilead Sciences and Omega Funds.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Sign up to see all 6 rounds
Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cymabay-therapeutics"><img src="https://indexed.vc/api/badge/company/cymabay-therapeutics" alt="Cymabay Therapeutics on Indexed.vc" width="260" height="76" /></a>